Table 2.
Comparison of blood glucose, blood lipids, and liver function levels between the two groups before intervention, 6 and 12 months after intervention (‾x ± s)
| Norm | Period of intervention | Groups | n | x ± s, points(95% CI) | t | P |
|---|---|---|---|---|---|---|
| FPG(mmol/L) | Before intervention | Control group | 104 | 10.86 ± 2.16 | 0.950 | 0.343 |
| Research group | 104 | 10.58 ± 2.09 | ||||
| Intervention for 6 months | Control group | 104 | 8.75 ± 1.68* | 5.911 | 0.000 | |
| Research group | 104 | 7.46 ± 1.46* | ||||
| Intervention for 12 months | Control group | 104 | 7.00 ± 1.32*# | 12.127 | 0.000 | |
| Research group | 104 | 5.12 ± 0.87*# | ||||
| 2hPG(mmol/L) | Before intervention | Control group | 104 | 12.68 ± 2.15 | 0.442 | 0.659 |
| Research group | 104 | 12.81 ± 2.09 | ||||
| Intervention for 6 months | Control group | 104 | 10.21 ± 1.72* | 9.214 | 0.000 | |
| Research group | 104 | 8.24 ± 1.34* | ||||
| Intervention for 12 months | Control group | 104 | 8.74 ± 1.32*# | 6.726 | 0.000 | |
| Research group | 104 | 7.55 ± 1.23*# | ||||
| FINS (mmol/L) | Before intervention | Control group | 104 | 12.84 ± 2.16 | 0.292 | 0.771 |
| Research group | 104 | 12.75 ± 2.29 | ||||
| Intervention for 12 months | Control group | 104 | 15.24 ± 3.91* | 4.323 | 0.000 | |
| Research group | 104 | 17.66 ± 4.16* | ||||
| Intervention for 12 months | Control group | 104 | 17.06 ± 4.56*# | 3.965 | 0.000 | |
| Research group | 104 | 19.46 ± 5.29*# | ||||
| TG (mmol/L) | Before intervention | Control group | 104 | 3.99 ± 1.52 | 0.540 | 0.590 |
| Research group | 104 | 3.87 ± 1.68 | ||||
| Intervention for 6 months | Control group | 104 | 3.02 ± 1.28* | 3.319 | 0.001 | |
| Research group | 104 | 2.46 ± 1.15* | ||||
| Intervention for 12 months | Control group | 104 | 2.62 ± 1.12*# | 5.139 | 0.000 | |
| Research group | 104 | 1.86 ± 1.01*# | ||||
| ALT(U/L) | Before intervention | Control group | 104 | 66.58 ± 12.48 | 0.130 | 0.896 |
| Research group | 104 | 66.74 ± 12.06 | ||||
| Intervention for 6 months | Control group | 104 | 59.19 ± 10.16* | 2.276 | 0.024 | |
| Research group | 104 | 56.09 ± 9.47* | ||||
| Intervention for 12 months | Control group | 104 | 56.45 ± 8.16*# | 2.035 | 0.043 | |
| Research group | 104 | 54.26 ± 7.56*# |
Note:# Compared with this group after 6 months of intervention, P < 0.05; * Compared with before intervention in this group, P < 0.05; FPG: Fasting blood glucose; 2hPG: 2 h postprandial blood glucose; FINS: Fasting serum insulin; TG: Triglyceride; ALT: Alanine transaminase. A 95% CI indicates that there is a 95% probability that the estimate will fall within that interval in repeated sampling